Feb 13, 2026 08:09AM
Dec 9, 2025 05:04PM
Nov 13, 2025 07:00AM
Oct 23, 2025 05:12PM
Apr 22, 2025 07:00AM
Apr 1, 2025 07:00AM
Mar 26, 2025 07:00AM Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting
Feb 25, 2025 07:05AM
Feb 25, 2025 07:00AM
Feb 13, 2025 10:28AM
Feb 5, 2025 07:00AM
Dec 13, 2024 08:30AM
Dec 5, 2024 07:35AM
Nov 27, 2024 07:02AM Medicenna Therapeutics (MDNA): Updated MDNA11 Monotherapy and Combination Clinical Data from the Ongoing Phase 1/2 ABILITY-1 Study to be Presented at the 2024 Immunotherapy Bridge Conference
Nov 27, 2024 07:00AM
Nov 25, 2024 07:30AM
Nov 15, 2024 07:30AM
Nov 13, 2024 07:00AM
Nov 11, 2024 07:00AM
Nov 8, 2024 10:00AM
Oct 4, 2024 09:07AM Medicenna to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Sep 26, 2024 05:00PM
Sep 9, 2024 07:32AM
Sep 5, 2024 07:00AM
Aug 27, 2024 07:00AM
Aug 15, 2024 07:31AM
Aug 15, 2024 07:30AM
Aug 1, 2024 07:00AM Medicenna Reports First Quarter Fiscal 2025 Financial Results and Announces First Complete Responder with MDNA11 Monotherapy
Jun 27, 2024 08:18AM
Jun 26, 2024 07:47AM
Jun 3, 2024 08:00AM
May 31, 2024 09:29AM
May 22, 2024 07:00AM
May 13, 2024 07:00AM
Apr 24, 2024 10:05AM Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting
Apr 10, 2024 06:32AM
Apr 10, 2024 06:30AM
Apr 9, 2024 04:30PM
Apr 9, 2024 12:01PM
Apr 9, 2024 12:01PM
Apr 4, 2024 07:00AM
Mar 6, 2024 07:00AM Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting
Feb 14, 2024 07:30AM
Feb 13, 2024 07:00AM
Jan 12, 2024 05:36PM
Jan 9, 2024 07:00AM
Dec 21, 2023 07:30PM
Dec 19, 2023 07:00AM
Nov 17, 2023 07:00AM Medicenna Announces Compelling Survival Benefit from Phase 2b Study of Bizaxofusp in Recurrent Glioblastoma at the 28th Annual Meeting of the Society for NeuroOncology
Nov 14, 2023 08:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All